
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Hukyndra | Adalimumab | 2021-11-15 | ||
| Kinpeygo | Budesonide | 2022-07-15 | 2026-2043 | |
| Libmyris | Adalimumab | 2021-11-12 | ||
| Movymia | Teriparatide | 2017-01-11 | 2025 | |
| Oyavas | Bevacizumab | 2021-03-26 | ||
| Silapo | Epoetin | 2007-12-18 | ||
| Ximluci | Ranibizumab | 2022-11-09 |
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|